In addition, SMAD4 loss in colorectal cancer has been associated with higher tumor and nodal stage, shorter relapse-free survival in 5-FU-based chemotherapy, and less immune infiltration in the tumor microenvironment [10,11]. The gene discussed is SMAD4; the disease is neoplasm.